141 related articles for article (PubMed ID: 31653819)
1. Genomic alterations underlying spinal metastases in pediatric H3K27M-mutant pineal parenchymal tumor of intermediate differentiation: case report.
Fomchenko EI; Erson-Omay EZ; Kundishora AJ; Hong CS; Daniel AA; Allocco A; Duy PQ; Darbinyan A; Marks AM; DiLuna ML; Kahle KT; Huttner A
J Neurosurg Pediatr; 2019 Oct; 25(2):121-130. PubMed ID: 31653819
[TBL] [Abstract][Full Text] [Related]
2. ATRX Mutations in Pineal Parenchymal Tumors of Intermediate Differentiation.
MartÃnez H; Nagurney M; Wang ZX; Eberhart CG; Heaphy CM; Curtis MT; Rodriguez FJ
J Neuropathol Exp Neurol; 2019 Aug; 78(8):703-708. PubMed ID: 31225581
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic strategy for pineal parenchymal tumor of intermediate differentiation (PPTID): case report of PPTID with malignant transformation to pineocytoma with leptomeningeal dissemination 6 years after surgery.
Bando T; Ueno Y; Shinoda N; Imai Y; Ichikawa K; Kuramoto Y; Kuroyama T; Shimo D; Mikami K; Hori S; Matsumoto M; Hirai O
J Neurosurg; 2018 Jul; 130(6):2009-2015. PubMed ID: 30028263
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive genomic study of 390 H3F3A-mutant pediatric and adult diffuse high-grade gliomas, CNS WHO grade 4.
Williams EA; Brastianos PK; Wakimoto H; Zolal A; Filbin MG; Cahill DP; Santagata S; Juratli TA
Acta Neuropathol; 2023 Sep; 146(3):515-525. PubMed ID: 37524847
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Implication of Patient Age in H3K27M-Mutant Midline Gliomas.
Vuong HG; Ngo TNM; Le HT; Jea A; Hrachova M; Battiste J; McNall-Knapp R; Dunn IF
Front Oncol; 2022; 12():858148. PubMed ID: 35371982
[TBL] [Abstract][Full Text] [Related]
6. Identification of prognostic markers in diffuse midline gliomas H3K27M-mutant.
Dufour C; Perbet R; Leblond P; Vasseur R; Stechly L; Pierache A; Reyns N; Touzet G; Le Rhun E; Vinchon M; Maurage CA; Escande F; Renaud F
Brain Pathol; 2020 Jan; 30(1):179-190. PubMed ID: 31348837
[TBL] [Abstract][Full Text] [Related]
7. Unedited microneurosurgery of a high-grade pineal parenchymal tumor of intermediate differentiation.
Choque-Velasquez J; Hernesniemi J
Surg Neurol Int; 2018; 9():248. PubMed ID: 30603232
[TBL] [Abstract][Full Text] [Related]
8. Spinal Dissemination of Pineal Parenchymal Tumors of Intermediate Differentiation Over 10 Years After Initial Treatment: A Case Report.
Miyazaki A; Makino K; Shinojima N; Yamashita S; Mikami Y; Mukasa A
Cureus; 2024 Mar; 16(3):e57147. PubMed ID: 38681294
[TBL] [Abstract][Full Text] [Related]
9. Radiation therapy for pineal parenchymal tumor of intermediate differentiation: A case series and literature review.
Liu C; Carmicheal J; Baine MJ; Zhang C
J Cent Nerv Syst Dis; 2023; 15():11795735231160036. PubMed ID: 36949932
[TBL] [Abstract][Full Text] [Related]
10. Recurrent pineal parenchymal tumor of intermediate differentiation with intratumoral hemorrhage: A case report and review of the literature.
Chen YL; Tai LH; Lieu AS
Rare Tumors; 2023; 15():20363613231177537. PubMed ID: 37223544
[TBL] [Abstract][Full Text] [Related]
11. Pineal parenchymal tumor of intermediate differentiation: a systematic review and contemporary management of 389 cases reported during the last two decades.
Takase H; Tanoshima R; Singla N; Nakamura Y; Yamamoto T
Neurosurg Rev; 2022 Apr; 45(2):1135-1155. PubMed ID: 34668090
[TBL] [Abstract][Full Text] [Related]
12. Prognosticating survival of pineal parenchymal tumors of intermediate differentiation (PPTID) by grade.
Lu VM; Luther EM; Eichberg DG; Morell AA; Shah AH; Komotar RJ; Ivan ME
J Neurooncol; 2021 Nov; 155(2):165-172. PubMed ID: 34606044
[TBL] [Abstract][Full Text] [Related]
13. Pineal parenchymal tumor of intermediate differentiation with late spinal dissemination 13 years after initial surgery: illustrative case.
Kato H; Tanei T; Nishimura Y; Nagashima Y; Ishii M; Nishii T; Fukaya N; Abe T; Saito R
J Neurosurg Case Lessons; 2023 Feb; 5(7):. PubMed ID: 36794736
[TBL] [Abstract][Full Text] [Related]
14. Survival and Malignant Transformation of Pineal Parenchymal Tumors: A 30-Year Retrospective Analysis in a Single-Institution.
Park TH; Kim SK; Phi JH; Park CK; Kim YH; Paek SH; Lee CH; Park SH; Koh EJ
Brain Tumor Res Treat; 2023 Oct; 11(4):254-265. PubMed ID: 37953449
[TBL] [Abstract][Full Text] [Related]
15. Integrated Genomic Characterization of a Pineal Parenchymal Tumor of Intermediate Differentiation.
Kang YJ; Bi WL; Dubuc AM; Martineau L; Ligon AH; Berkowitz AL; Aizer AA; Lee EQ; Ligon KL; Ramkissoon SH; Dunn IF
World Neurosurg; 2016 Jan; 85():96-105. PubMed ID: 26226092
[TBL] [Abstract][Full Text] [Related]
16. H3K27M-mutant diffuse midline glioma presenting as synchronous lesions involving pineal and suprasellar region: A case report and literature review.
Lim JX; Leong A; Tan AP; Tan CL; Nga VDW
J Clin Neurosci; 2020 Nov; 81():144-148. PubMed ID: 33222904
[TBL] [Abstract][Full Text] [Related]
17. Clinical Features of Pineal Parenchymal Tumors of Intermediate Differentiation (PPTID): A Single-Institution Series.
Kunigelis KE; Kleinschmidt-DeMasters BK; Youssef AS; Lillehei KO; Ormond DR
World Neurosurg; 2021 Nov; 155():e229-e235. PubMed ID: 34418607
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Genomic Profiling of 282 Pediatric Low- and High-Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation Signatures.
Johnson A; Severson E; Gay L; Vergilio JA; Elvin J; Suh J; Daniel S; Covert M; Frampton GM; Hsu S; Lesser GJ; Stogner-Underwood K; Mott RT; Rush SZ; Stanke JJ; Dahiya S; Sun J; Reddy P; Chalmers ZR; Erlich R; Chudnovsky Y; Fabrizio D; Schrock AB; Ali S; Miller V; Stephens PJ; Ross J; Crawford JR; Ramkissoon SH
Oncologist; 2017 Dec; 22(12):1478-1490. PubMed ID: 28912153
[TBL] [Abstract][Full Text] [Related]
19. A Pineal Parenchymal Tumor of Intermediate Differentiation in an Octogenarian Contains a Rare
Jones VM; Kanter JH; Russo GA; Simmons NE; Tafe LJ; Zanazzi GJ
Int J Surg Pathol; 2023 Oct; ():10668969231201411. PubMed ID: 37855103
[TBL] [Abstract][Full Text] [Related]
20. Histopathologic review of pineal parenchymal tumors identifies novel morphologic subtypes and prognostic factors for outcome.
Raleigh DR; Solomon DA; Lloyd SA; Lazar A; Garcia MA; Sneed PK; Clarke JL; McDermott MW; Berger MS; Tihan T; Haas-Kogan DA
Neuro Oncol; 2017 Jan; 19(1):78-88. PubMed ID: 27282397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
